πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

4,838 results for β€œSP” Clear

  1. Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)

    GlaxoSmithKline

    Respiratory Syncytial Virus Infections

    phase 2 small molecule active

    1 trial

  2. Arm 1： Standard Synchronous Group

    The First People's Hospital of Lianyungang

    Advanced Non-Small Cell Lung Cancer (NSCLC)

    phase 2 small molecule active

    1 trial

  3. Arm A

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    phase 2 small molecule active

    1 trial

  4. Arm1

    Hospital Authority, Hong Kong

    Oral Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  5. Asparaginase Erwinia chrysanthemi

    Jazz Pharmaceuticals Ireland Limited

    B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative

    phase 2 small molecule active

    1 trial

  6. Aspirin

    Cardiff Oncology

    Venous Leg Ulcer

    phase 2 small molecule terminated

    1 trial

  7. Aspirin

    United Therapeutics Europe Ltd

    Vestibular Schwannoma

    phase 2 small molecule active

    1 trial

  8. Aspirin 75mg

    United Therapeutics Europe Ltd

    Acute Lung Injury

    phase 2 small molecule completed

    1 trial

  9. Aspirin Challenge

    Regeneron UK Limited

    Aspirin-exacerbated Respiratory Disease

    phase 2 small molecule completed

    1 trial

  10. Atezolizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Small-cell Lung Cancer

    phase 2 small molecule active

    1 trial

  11. Atorvastatin

    Hospital Authority, Hong Kong

    Vitiligo

    phase 2 small molecule completed

    1 trial

  12. Atorvastatin

    The First People's Hospital of Lianyungang

    Myocardial Infarction

    phase 2 small molecule active

    1 trial

  13. Aumolertinib

    The First People's Hospital of Lianyungang

    Lung Cancer

    phase 2 small molecule active

    1 trial

  14. Aumolertinib Oral Tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer Stage IV

    phase 2 small molecule active

    1 trial

  15. Autologous BCMA-targeting CAR T cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multiple Myeloma in Relapse

    phase 2 mab active

    1 trial

  16. Autologous CD5 CAR T-cells

    The First People's Hospital of Lianyungang

    T-Cell Acute Lymphocytic Leukemia

    phase 2 small molecule active

    1 trial

  17. Autologous bone marrow mononuclear cell transplantation

    EuroGen Pharmaceuticals Ltd

    Spinal Cord Injury

    phase 2 mab terminated

    1 trial

  18. Autologous hematopoietic stem cell infusion

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prolonged Cytopenia Following CAR-T Therapy

    phase 2 mab active

    1 trial

  19. Avapritinib, azacitidine, Venetoclax

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    AML (Acute Myelogenous Leukemia)

    phase 2 small molecule active

    1 trial

  20. Avastin 25 mg/ml concentrate for solution for infusion.

    Disc Medicine

    Barrett's esophagus, Colon carcinoma, gastrointestinal dysplasia

    phase 2 small molecule active

    1 trial

  21. Avatrombopag

    Hospital Authority, Hong Kong

    Chemotherapy-induced Thrombocytopenia

    phase 2 small molecule active

    1 trial

  22. Avatrombopag

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Severe Aplastic Anemia

    phase 2 small molecule active

    2 trials

  23. Avatrombopag

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immune Thrombocytopenia

    phase 2 small molecule active

    1 trial

  24. Azacitidine

    Janssen Cilag International NV

    Myelodysplastic Syndromes

    phase 2 small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources